Sequana Medical Stock price
Is Sequana Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Sequana Medical Stock Analysis
Analyst Opinions
7 Analysts have issued a Sequana Medical forecast:
Analyst Opinions
7 Analysts have issued a Sequana Medical forecast:
Don't miss a Thing! We will send you all news about Sequana Medical directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium.
| Head office | Belgium |
| CEO | Ian Crosbie |
| Employees | 48 |
| Founded | 2018 |
| Website | www.sequanamedical.com |


